Broadwood Partners, L.P. Staar Surgical CO (STAA) insider trading activity

Broadwood Partners, L.P. is > 10% Shareholder of STAAR SURGICAL CO. Currently has a direct ownership of 11.3 Million shares of STAA, which is worth approximately $173 Million. The most recent transaction as insider was on Feb 14, 2025, when has been sold 36,532 shares (Common Stock) at a price of $15.49 per share, resulting in proceeds of $565,880. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.3M

4.84% 3M change

4.84% 12M change

Total Value Held $173 Million

BROADWOOD PARTNERS, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 14 2025	BUY Open market or private purchase	$565,880 $15.49 p/Share	36,532 Added 0.32%	11,289,437 Common Stock
Feb 13 2025	BUY Open market or private purchase	$1,826,066 $15.84 p/Share	115,282 Added 1.01%	11,252,905 Common Stock
Feb 12 2025	BUY Open market or private purchase	$3,865,682 $14.89 p/Share	259,616 Added 2.28%	11,137,623 Common Stock
Jan 16 2025	BUY Open market or private purchase	$176,751 $21.5 p/Share	8,221 Added 0.08%	10,878,007 Common Stock
Jan 14 2025	BUY Open market or private purchase	$453,986 $21.46 p/Share	21,155 Added 0.19%	10,869,786 Common Stock
Dec 18 2024	BUY Open market or private purchase	$559,590 $24.33 p/Share	23,000 Added 0.21%	10,848,631 Common Stock
Dec 17 2024	BUY Open market or private purchase	$90,946 $24.58 p/Share	3,700 Added 0.03%	10,825,631 Common Stock
Dec 16 2024	BUY Open market or private purchase	$1,310,215 $24.49 p/Share	53,500 Added 0.49%	10,821,931 Common Stock
May 09 2024	BUY Open market or private purchase	$42 $42.56 p/Share	1 Added 0.0%	10,768,431 Common Stock
Jan 08 2024	BUY Open market or private purchase	$109,578 $27.11 p/Share	4,042 Added 0.04%	10,768,430 Common Stock
Jan 05 2024	BUY Open market or private purchase	$4,495,131 $28.68 p/Share	156,734 Added 1.44%	10,764,388 Common Stock
Jan 04 2024	BUY Open market or private purchase	$1,828,441 $28.91 p/Share	63,246 Added 0.59%	10,607,654 Common Stock
Jan 03 2024	BUY Open market or private purchase	$190,156 $28.93 p/Share	6,573 Added 0.06%	10,544,408 Common Stock
Nov 30 2023	BUY Open market or private purchase	$5,583,553 $31.42 p/Share	177,707 Added 1.66%	10,537,835 Common Stock
Nov 29 2023	BUY Open market or private purchase	$5,078,304 $31.68 p/Share	160,300 Added 1.52%	10,360,128 Common Stock
Nov 28 2023	BUY Open market or private purchase	$3,095,729 $31.92 p/Share	96,984 Added 0.94%	10,199,828 Common Stock
Nov 13 2023	BUY Open market or private purchase	$16,751 $33.04 p/Share	507 Added 0.01%	10,102,844 Common Stock
Nov 10 2023	BUY Open market or private purchase	$1,123,293 $32.73 p/Share	34,320 Added 0.34%	10,102,337 Common Stock
Nov 09 2023	BUY Open market or private purchase	$4,664,800 $33.32 p/Share	140,000 Added 1.37%	10,068,017 Common Stock
Nov 08 2023	BUY Open market or private purchase	$4,699,477 $33.71 p/Share	139,409 Added 1.38%	9,928,017 Common Stock
Nov 07 2023	BUY Open market or private purchase	$331,145 $34.03 p/Share	9,731 Added 0.1%	9,788,608 Common Stock
Nov 06 2023	BUY Open market or private purchase	$5,622,975 $34.16 p/Share	164,607 Added 1.66%	9,778,877 Common Stock
Nov 03 2023	BUY Open market or private purchase	$18,751 $36.06 p/Share	520 Added 0.01%	9,614,270 Common Stock
Nov 02 2023	BUY Open market or private purchase	$5,160,487 $35.83 p/Share	144,027 Added 1.48%	9,613,750 Common Stock
Oct 06 2023	BUY Open market or private purchase	$2,832,748 $37.62 p/Share	75,299 Added 0.79%	9,469,723 Common Stock

Also insider at

LCTX

Lineage Cell Therapeutics, Inc. Healthcare

Director

CMRO

COMARCO INC

> 10% Shareholder

OCX

Oncocyte Corp Healthcare

> 10% Shareholder

BPL